[Functional hyperandrogenism--classification, etiology, diagnosis and therapy]

Area of Science:

• Endocrinology
• Molecular Biology
• Genetics

Context:

• Functional hyperandrogenism (FHA) encompasses diverse organ system-specific conditions.
• Current classifications, including polycystic ovary syndrome (PCOS), lack precision.
• Advances in molecular biology offer new insights into FHA pathophysiology.

Purpose:

• To propose a revised classification of functional hyperandrogenism.
• To highlight the need for distinct diagnostic and therapeutic strategies for FHA subtypes.
• To advocate for replacing the term PCOS with more accurate descriptions.

Summary:

• The paper presents a novel classification of functional hyperandrogenism (FHA) integrating clinical experience with molecular biology data.
• FHA is presented as a collection of distinct entities requiring tailored approaches, challenging the broad use of the term polycystic ovary syndrome (PCOS).
• While etiological understanding remains incomplete for most FHA groups, the FHA III-group is detailed, and future genetic screening methods like microarrays are anticipated to elucidate underlying mechanisms.

Impact:

• This work aims to refine the understanding and management of hyperandrogenic disorders.
• It paves the way for more precise diagnostic criteria and personalized therapeutic interventions.
• The proposed classification may lead to improved patient outcomes by addressing the specific needs of individuals with FHA.